Mission
elbion discovers and develops new small molecule drugs. Central nervous system diseases and immunology disorders with high unmet medical need and high commercial potential are at the center of elbion's products pipeline, which covers all stages from early "hits" to advanced clinical projects.
Latest News
JANUARY 15, 2008 - elbion Partners with Oakwood Laboratories for Sustained Release Naltrexone Treatment for Alcohol Dependence … more
